
The FDA just funded a jury of AI judges for radiology reports.
Not one AI. A panel of them. Cross-examining each other.
On September 16, 2026, the FDA awarded Cognita Imaging a $1.29 million research contract to build what the company calls an "LLMs-as-a-jury" evaluation framework for autonomous, generative AI radiology reports. The 18-month contract was funded under the FDA's Broad Agency Announcement program for advanced research and development in regulatory science, effective June 22, 2026.
This is not a product clearance. It is the FDA funding the infrastructure to evaluate a whole new category of AI before that category overwhelms the agency's ability to review it. That distinction matters enormously to anyone building, buying, or deploying radiology AI.



